Cagent Vascular is the first and only company to commercialize an angioplasty balloon with integrated serrations, introducing a new category of endovascular treatment: Serration Remodeling Therapy (SRT). Headquartered in Wayne, PA, our mission is to improve outcomes for patients with Peripheral Artery Disease (PAD) and Chronic Limb-Threatening Ischemia (CLTI) by changing the way physicians treat diseased vessels. Our flagship device, the SerranatorĀ® PTA Serration Balloon Catheter, creates controlled micro-fissures in the arterial wall, driving vessel wall remodeling, not just dilation. The result: greater lumen gain, reduced recoil, and improved vessel compliance across lesion morphologies. It's time for a new standard of care. It starts with Serranator.
| Website | http://www.cagentvascular.com |
| Revenue | $8 million |
| Employees | 104 (72 on RocketReach) |
| Founded | 2014 |
| Address | 150 Strafford Avenue Suite 315, Wayne, Pennsylvania 19087, US |
| Phone | +1 610-688-2006 |
| Technologies |
JavaScript
,
HTML
,
PHP
+10 more
(view full list)
|
| Industry | Medical Equipment Manufacturing, Manufacturing General, Manufacturing |
| Competitors | Medtronic, Abbott, Stryker, Philips, Cardinal Health, Boston Scientific, Cook Medical, CR Bard - Europe, Middle East and Africa (EMEA), Terumo, Johnson & Johnson MedTech Germany +28 more (view full list) |
| SIC | SIC Code 384 Companies, SIC Code 38 Companies |
| NAICS | NAICS Code 33 Companies, NAICS Code 339 Companies |
Looking for a particular Cagent Vascular employee's phone or email?
The Cagent Vascular annual revenue was $8 million in 2026.
Brian Walsh is the Chairman and CEO of Cagent Vascular.
72 people are employed at Cagent Vascular.
Cagent Vascular is based in Wayne, Pennsylvania.
The NAICS codes for Cagent Vascular are [33, 339].
The SIC codes for Cagent Vascular are [384, 38].